Name that brand

Share this article:

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, along with some clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Ave 2: The Story of Medical Advertising in America 1990-2008. Please e-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is December 31, 2011. The winner will be selected randomly from all the correct entries.

Brand X makes an urgent call
The maker of this month's Brand X is running consumer ads depicting an iPhone full of increasingly, well, urgent texts from its owner's bladder. The creative plays to the exasperation that sufferers feel. The drug met its primary endpoint in a 12-week study unveiled last week. That's good news for the 33 million American sufferers of the condition it treats—and for the manufacturer, which will need all the help it can get to recuperate after a nasty tumble over the patent cliff.

OCTOBER'S WINNER...
Congratulations to Vira L. Katolik, Marketing Director at Digitas Health, for correctly identifying an ad for Crestor, AstraZeneca's medication to lower cholesterol.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?